Online Expert Panels

Powered by AI


"I am always recommending people join the Currnt platform.
It's a great way to stay current and expand your thinking."

Dawn L. I. Houghton, Innovation Consultant

Next-Generation Oncology Treatments

We're assembling an online advisory panel to discuss the trends and technologies shaping the future of Oncology treatments. We'll explore a range of current and emerging topics, such as the decline of chemo-therapy, anti-cancer agents, tumor-agnostic prescriptions, patient-reported outcomes, and beyond -- over a 4-day panel of online engagement.

A professional facilitator will lead an open and honest dialogue. This is a unique opportunity to demonstrate your knowledge, learn from your equal-caliber peers, and gain recognition for advancing innovation in your field. You will also receive a $200 honorarium.

Project Objectives:
- Better understand the needs of the market.
- Explore and map the current landscape.
- Identify future directions.
- Determine a recommended path.

This engagement is expected to launch in mid-January.

peopleSeeking Expert Participation

- Medical Oncologists
- Hematologist-Oncologists
- Oncology Specialists
- Surgical Oncologists
- Board Eligible; Board Certified
- US Practicing Doctors


Darryl Glover

Pharmacist Consultant @ KPMG, BlueShield, & You for MTM Implementation, Tech, Marketing, Management, Strategy, & Ops

Top Applicants

100% Online (No travel)
At Convenience (No meetings)
No Commitment (Opt out at any time)

flag Expectations

Log in at least once a day, when convenient to you, to answer the daily question posted by the facilitator over the 4-day engagement. This may include open-ended questions, simple surveys and responding to peers.

stars Value

- Learn about new developments and trends in your area of expertise
- Connect with other high-caliber peers and expand your network
- Enhance your reputation as a leading thinker on topics matching your passion and expertise
- Earn $200 paid immediately after the engagement

lockThis panel is now closed to new applicants.